This article is from the Australian Property Journal archive
UK drug giant Noumed Pharmaceuticals’ $100 million manufacturing plant in Adelaide’s north-east has received approval after four years of negotiations, paving the way for construction to begin.
Leasing agent Kym Hutchins of JLL said the deal began in 2020, with the stage one initial lease by Noumed for a 3,000 sqm office warehouse within Terre Property’s Nexus North Industrial Estate in Salisbury South. Then followed a more ambitious stage two plan for a 26,000 sqm state-of-the-art pharmaceutical manufacturing facility, Noumed’s first in Australia.
The company received a $20 million incentive from the federal government to commit to the facility.
Hutchins said the deal was a long time in the making.
“Deals like these are always a lengthy process, with many hurdles along the way,” he said.
“The pre-lease new facility was not a foregone conclusion.
“It was not until 2024 that approvals and documentation were able to be signed off; it was an exciting moment for all concerned when it finally came together.”
Noumed’s new plant is being built on a 43,000 sqm site and forms a key part of South Australia’s 10-year health and medical industries strategy.
“Noumed Pharmaceuticals could have chosen anywhere else in the world, but they didn’t, which means South Australia has ticked a number of key metrics for them to relocate such a big manufacturing facility here,” Hutchins said.
The pharmaceutical giant will join major companies Asahi, Telstra, Haighs Chocolates and FJT Logistics as neighbours at the 15-hectare, master-planned estate, which is now fully committed.
On completion, the facility will be the most modern of its kind in Australia and allow certain over-the-counter pharmaceutical products to be manufactured in South Australia rather than overseas, giving a competitive advantage to Noumed’s clients with shorter lead times and making it a supplier that can react quickly to individual needs.
Construction of the manufacturing plant will create 250 jobs, and Noumed is expected to employ more than 180 people when local production begins in 2026.
Mark Brammy, Terre Property Partners CEO, said, “The location is an ideal place for high-tech industries and we’re looking forward to Noumed leading the way in Australian pharmaceutical manufacturing, right here in South Australia”.
